Obesity rate declining in US. Use of GLP-1 injectables for weight loss has more than doubled since early 2024.
28
votes
-
-
Half of people on weight loss drugs quit within one year, Danish study finds – more likely to stop taking the drugs if they were younger, lived in poorer areas, or were men
24 votes -
Novo Nordisk's ad campaign, which aimed to speak ‘without filters’ by declaring obesity a disease, has faced strong criticism on social media and from some scientific societies
21 votes -
Eleven spouses on what it’s like to live with someone on Ozempic
36 votes -
The GLP-1 compounding loophole
24 votes -
The growing scientific case for using Ozempic and other GLP-1s to treat opioid, alcohol, and nicotine addiction
39 votes -
Most patients using weight-loss drugs like Wegovy stop within a year, data show
10 votes